3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Non-Small-Cell Lung
59
Carcinoma, Hepatocellular
43
Colorectal Neoplasms
32
Stomach Neoplasms
28
Esophageal Squamous Cell Carcinoma
27
Squamous Cell Carcinoma of Head and Neck
20
Esophageal Neoplasms
14
Small Cell Lung Carcinoma
13
Neoplasm Metastasis
13
Lung Neoplasms
13
Head and Neck Neoplasms
12
Advanced Solid Tumor
12
Cholangiocarcinoma
11
Triple Negative Breast Neoplasms
10
Rectal Neoplasms
10
Nasopharyngeal Carcinoma
10
Melanoma
10
Uterine Cervical Neoplasms
9
Recurrence
9
Neoplasms
9
Colonic Neoplasms
9
Pancreatic Neoplasms
7
Urinary Bladder Neoplasms
6
Solid Tumor
6
Carcinoma, Transitional Cell
6
Breast Neoplasms
6
Sarcoma
5
Lymphoma, Extranodal NK-T-Cell
5
Lymphoma
5
Hodgkin Disease
5
Interventions
Radiotherapy
2
Exercise
2
Deglutition
2
Cisplatin
2
Carboplatin
2
Brachytherapy
2
Acupuncture Therapy
2
tislelizumab
1
epigallocatechin gallate
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
auricularum
1
Tablets
1
Standard of Care
1
Resistance Training
1
Range of Motion, Articular
1
Radiotherapy, Intensity-Modulated
1
Radiation
1
Pravastatin
1
Paclitaxel
1
Niacinamide
1
Musculoskeletal Manipulations
1
Lead
1
Hyaluronic Acid
1
Gastropexy
1
Fundoplication
1
Fluorouracil
1
Fibroblast Growth Factor 7
1
Esophagectomy
1
Endoscopy, Digestive System
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Deglutition Disorders
×
tislelizumab
×
Clear all
NCT05596890
2022-11-28
PICCRT
Guangdong Provincial People's Hospital
Phase 2
Unknown
50 enrolled